Market Trends of India Insulin Infusion Pump Industry
Insulin Pump is Expected to Witness Growth Over the Forecast Period
An insulin pump is a device that automatically distributes insulin on a continuous or as-needed basis. The pump is modeled after the human pancreas. The insulin infusion pump can be used instead of the standard regimen of daily injections or an insulin pen. Insulin pump treatment is a well-known insulin delivery technique for people with type 1 diabetes (T1DM). Pumps are a recognized, time-tested treatment alternative for T1DM patients of all ages, providing near-physiological insulin administration when the pancreas does not make insulin. There are also pump variants with remote controllers that allow parents to suspend or bolus insulin from a distance while their child is playing or eating. When compared to injections, insulin infusion pumps prevent big fluctuations in blood glucose levels, cause less discomfort, and dispense more precisely. The benefits of insulin pumps over traditional delivery systems are projected to drive market growth.
Continuous subcutaneous insulin infusion (CSII, also known as insulin pumps) and continuous glucose monitoring systems (CGMs) have significantly improved patient care and quality of life and are commonly utilized in the ambulatory context. This technology is increasingly being employed in the healthcare setting.
Because of the rising obesity incidence, increasing hereditary risks for type 2 diabetes, and an increasing number of Type 1 diabetes patients, the insulin infusion pump industry is expected to expand further.
Rising diabetes prevalence
In India, Diabetes Population is expected to increase with a CAGR of more than 1% over the forecast period.
Diabetes already affects more than 80 million Indians and is expected to affect 10% of the Indian population by 2027. Obesity, particularly central obesity and increased visceral fat as a result of inactivity, as well as intake of high-calorie/high-fat/high-sugar meals, are key risk factors for diabetes among Indians. The country's most prevalent work culture, which consists of sitting for hours in one position and eating fast food with little or no physical activity, is a key contributor to diabetes in the working-age population, resulting in a considerable increase in diabetes cases in India.
Diabetes accounts for 10% of global health spending in India, according to the International Diabetes Federation (IDF). Noncommunicable diseases (NCDs) account for 60% of all fatalities in India, according to the Ministry of Health and Family Welfare of the Government of India. Diabetes, cardiovascular disease, cancer, chronic respiratory illness, and other non-communicable diseases are all examples of non-communicable diseases. The National Programme for the Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) involves medical education, school health awareness, and diabetic urban design to prevent and control major NCDs. Diabetes is a data management disease that exemplifies how collecting real-world health and treatment data enables integrated and personalized chronic illness management. When making collaborative treatment decisions, both patients and diabetic care professionals use continually gathered metabolic, pharmaceutical, and lifestyle data.
Diabetes self-management is aided by digital health technologies, such as digital health applications. Diabetes apps make it easier to undertake lifestyle changes for diabetes prevention and treatment and check the quality of blood glucose control and insulin dose. Other developments include the integration of Blood Glucose Monitoring with insulin calculators, automated insulin titration software, and remote coaching, which give patients with poorly controlled diabetes the extra support they need to improve critical outcomes, thereby improving market prospects in the coming years.
